Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Thomas

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
BMC Neuroscience|September 24, 2009
Imaging short- and long-term training success in chronic aphasiaRicarda Menke, Marcus Meinzer, Harald Kugel, et al.
Joint Bone Spine|November 16, 2024
Intestinal barrier biomarkers in adult patients with juvenile idiopathic arthritis in transitionSophie Hecquet, Marion Thomas, Eleonore Parisel, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Scientific Reports|February 28, 2025
Inflammatory and angiogenic serum profile of refractory rheumatoid arthritisManon Lesturgie-Talarek, Virginie Gonzalez, Alice Combier, et al.
Rheumatology (Oxford, England)|March 31, 2022
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infectionJérôme Avouac, Roba Ghossan, Omar Al Tabaa, et al.
Lancet (London, England)|March 4, 2017
Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care settingCaterina Breitenstein, Tanja Grewe, Agnes Flöel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patientsYann Nguyen, Adrien Flahault, Nathalie Chavarot, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
BMC Neuroscience|September 24, 2009
Imaging short- and long-term training success in chronic aphasiaRicarda Menke, Marcus Meinzer, Harald Kugel, et al.
Joint Bone Spine|November 16, 2024
Intestinal barrier biomarkers in adult patients with juvenile idiopathic arthritis in transitionSophie Hecquet, Marion Thomas, Eleonore Parisel, et al.
Joint Bone Spine|December 27, 2022
Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthoodAlice Combier, Camelia Frantz, Julien Wipff, et al.
Scientific Reports|February 28, 2025
Inflammatory and angiogenic serum profile of refractory rheumatoid arthritisManon Lesturgie-Talarek, Virginie Gonzalez, Alice Combier, et al.
Rheumatology (Oxford, England)|March 31, 2022
Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infectionJérôme Avouac, Roba Ghossan, Omar Al Tabaa, et al.
Lancet (London, England)|March 4, 2017
Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care settingCaterina Breitenstein, Tanja Grewe, Agnes Flöel, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 4, 2022
Pre-exposure prophylaxis with tixagevimab and cilgavimab (Evusheld) for COVID-19 among 1112 severely immunocompromised patientsYann Nguyen, Adrien Flahault, Nathalie Chavarot, et al.
Pageof 4